International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Fibromyalgia Syndrome: It’s more than just a mere syndrome

Sidrah Parvez, Ghizal Fatima, Hekmat B Alhmadi, Najah Hadi, Jan Fedacko

Department of Chemistry, College of Medicine, AL-Muthanna University, Samawah, Iraq; Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Iraq; Department of Gerontology and Geriatric, Medipark, University Research Park, PJ Safarik University, 040-11 Kosice, Slovakia

Article Information

Volume / Issue6 / 1 (2025)
Pages74-79
AccessOpen Access

Publication Timeline

  • Received06 December 2024
  • Accepted07 January 2025

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Fibromyalgia Syndrome (FMS) is a complex, chronic condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, cognitive difficulties, and a variety of other symptoms. Despite being one of the most common chronic pain conditions, affecting millions worldwide, FMS remains poorly understood and frequently misdiagnosed. This paper aims to delve deeper into the multifaceted nature of fibromyalgia, challenging the perception that it is merely a syndrome. The pathophysiology of FMS involves a combination of genetic, neurobiological, and environmental factors. Central sensitization, where the central nervous system becomes hypersensitive to pain stimuli, plays a crucial role. Additionally, imbalances in neurotransmitters, such as serotonin and norepinephrine, contribute to the heightened pain perception and emotional symptoms observed in FMS patients. The syndrome also often coexists with other conditions like irritable bowel syndrome, migraine, and temporomandibular joint disorders, further complicating its diagnosis and management. Traditional diagnostic criteria for FMS, based primarily on tender points and symptom reports, have evolved. Understanding the underlying mechanisms and interactions within the neuroendocrine-immune system is crucial for developing more effective interventions. This paper underscores the necessity of recognizing fibromyalgia as more than just a syndrome. It is a multifactorial condition with profound implications for patients' physical, emotional, and social well-being. Enhanced awareness, comprehensive diagnostic criteria, and integrated treatment strategies are essential for improving the quality of life for patients with FMS.

Keywords

FibromyalgiaBiomarkersPainSerotoninStress

References

  1. Koca TT, Seyithanoglu M, Sagiroglu S, Berk E, Dagli H. Frequency of audiological complaints in patients with fibromyalgia syndrome and its relationship with oxidative stress. Nigerian Journal of Clinical Practice. 2018 Oct;21(10):1271-1277. [Google Scholar][Crossref]
  2. Ablin JN, Buskila D. Update on the genetics of the fibromyalgia syndrome. Best Practice & Research Clinical Rheumatology. 2015;29:20 -8. doi:10.1016/j.berh.2015.04.018. [Google Scholar][Crossref]
  3. Parvez S, Fatima G, Das SK, Ahmad I. Serotonin role in fibromyalgia. Era's Journal of Medical Research. 2021 Jan 1;8(1). doi:10.24041/ejmr2021.10. [Google Scholar][Crossref]
  4. Buskila D, Sarzi-Puttini P. Biology and therapy of International Journal of Medical and All Body Health Research www.allmedicaljournal.com fibromyalgia. Genetic aspects of fibromyalgia syndrome. Arthritis Research & Therapy. 2006;8:218. doi:10.1186/ar2005. [Google Scholar][Crossref]
  5. Parvez S, Fatima G, Das SK, Ahmad I. Positive and negative association of vitamin D with fibromyalgia syndrome. Era's Journal of Medical Research. 2020;7(1):126-33. doi:10.24041/ejmr2020.21. [Google Scholar][Crossref]
  6. Park DJ, Lee SS. New insights into the genetics of fibromyalgia. Korean Journal of Internal Medicine. 2017;32:984-95. doi:10.3904/kjim.2016.207. [Google Scholar][Crossref]
  7. Ablin JN, Buskila D. Update on the genetics of the fibromyalgia syndrome. Best Practice & Research Clinical Rheumatology. 2015;29:20 -8. doi:10.1016/j.berh.2015.04.018. [Google Scholar][Crossref]
  8. Fatima G, Alhmadi H, Mahdi AA, Hadi N, Fedacko J, Magomedova A, Parvez S, Raza AM. Transforming diagnostics: A comprehensive review of advances in digital pathology. Cureus. 2024 Oct 19;16(10):e71890. doi:10.7759/cureus.71890. [Google Scholar][Crossref]
  9. Silioni I, Russell IJ, Stewart JM, Gleason RM, Theoharides TC. Neuropeptides CRH, SP, HK-1, and inflammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cells. Journal of Pharmacology and Experimental Therapeutics. 2016 Mar;356(3):664-72. [Google Scholar][Crossref]
  10. D’Agnelli S, Arendt-Nielsen L, Gerra MC, Zatorri K, Boggiani L, Baciarello M, Bignami E. Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers. Molecular Pain. 2019 Jan;15:1744806918819944. [Google Scholar][Crossref]
  11. Parvez S, Fatima G, Mahdi F, Hadi NR, Fedacko J. Assessment of the association of serotonin transporter gene (5-HTTVNTR & 5-HTTLPR) polymorphism in patients with fibromyalgia syndrome. Wiadomosci Lekarskie (Warsaw, Poland: 1960). 2023 Jan 1;76(6):1378-84. doi:10.36740/WLek202306108. [Google Scholar][Crossref]
  12. Parvez S, Fatima G, Mehdi F, Hadi NR, Fedacko J, Hadi N, Fedacko J. Relationship between vitamin D receptor gene BsmI polymorphism and fibromyalgia syndrome. Cureus. 2022 Jul 21;14(7). doi:10.7759/cureus.27113. [Google Scholar][Crossref]
  13. Parvez S, Fatima G, Mahdi F, Fedacko J, Hadi NR. Unraveling the clinico-genetic association of catechol-O-methyltransferase-rs4680 G>A gene polymorphism in women with fibromyalgia syndrome. Wiadomosci Lekarskie. 2022 Jan 1;75(10):2439 -44. doi:10.36740/WLek202210123. [Google Scholar][Crossref]
  14. Tiffon C. The impact of nutrition and environmental epigenetics on human health and disease. International Journal of Molecular Sciences. 2018 Nov 1;19(11):3425. [Google Scholar][Crossref]
  15. González-Flores D, López-Pingarrón L, Castaño MY, Gómez MÁ, Rodríguez AB, García JJ, Garrido M. Melatonin as a coadjuvant in the treatment of patients with fibromyalgia. Biomedicines. 2023 Jul 12;11(7):1964. [Google Scholar][Crossref]
  16. Kim TO, Park DI, Han YK, et al. Genome-wide analysis of the DNA methylation profile identifies the fragile histidine triad (FHIT) gene as a new promising biomarker of Crohn's disease. Journal of Clinical Medicine. 2020 May 4;9(5):1338. [Google Scholar][Crossref]
  17. Menzies V, Lyon DE, Archer KJ, et al. Epigenetic alterations and an increased frequency of micronuclei in women with fibromyalgia. Nursing Research and Practice. 2013;2013:795784. doi:10.1155/2013/795784. [Google Scholar][Crossref]
  18. Fajardo O, Meseguer V, Belmonte C, Viana F. TRPA1 channels mediate cold temperature sensing in mammalian vagal sensory neurons: pharmacological and genetic evidence. Journal of Neuroscience. 2008;28:7863-75. doi:10.1523/JNEUROSCI.1696-08.2008. [Google Scholar][Crossref]
  19. Ciampi de Andrade D, Maschietto M, Galhardoni R, et al. Epigenetics insights into chronic pain: DNA hypomethylation in fibromyalgia—a controlled pilot-study. Pain. 2017;158:1473 -80. doi:10.1097/j.pain.0000000000000932. [Google Scholar][Crossref]
  20. Andersen HH, Duroux M, Gazerani P. MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions. Neurobiology of Disease. 2014;71:159-68. doi:10.1016/j.nbd.2014.08.003. [Google Scholar][Crossref]
  21. Bjersing JL, Lundborg C, Bokarewa MI, Mannerkorpi K. Profile of cerebrospinal microRNAs in fibromyalgia. PLoS One . 2013;8:e78762 . doi:10.1371/journal.pone.0078762. [Google Scholar][Crossref]
  22. Bjersing JL, Bokarewa MI, Mannerkorpi K. Profile of circulating microRNAs in fibromyalgia and their relation to symptom severity: an exploratory study. Rheumatology International. 2015;35:635-42. doi:10.1007/s00296-014-3139-3. [Google Scholar][Crossref]
  23. Masotti A, Baldassarre A, Guzzo MP, Iannuccelli C, Barbato C, Di Franco M. Circulating microRNA profiles as liquid biopsies for the characterization and diagnosis of fibromyalgia syndrome. Molecular Neurobiology. 2017;54:7129-36. doi:10.1007/s12035-016-0235-2. [Google Scholar][Crossref]
  24. Jones KD, Gelbart T, Whisenant TC, et al. Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia. Clinical and Experimental Rheumatology. 2016;34:S89-98. [Google Scholar][Crossref]
  25. Dolcino M, Tinazzi E, Puccetti A, Lunardi C. Gene expression profiling in fibromyalgia indicates an autoimmune origin of the disease and opens new avenues for targeted therapy. Journal of Clinical Medicine. 2020;9:10.3390/jcm9061814. [Google Scholar][Crossref]
  26. Fatima G, Magomedova A, Parvez S. Biotechnology and sustainable development. Shineeks Publishers; 2024 Apr 14. [Google Scholar][Crossref]
  27. Assavarittirong C, Samborski W, Grygiel-Górniak B. Oxidative stress in fibromyalgia: from pathology to treatment. Oxidative Medicine and Cellular Longevity. 2022;2022(1):1582432. [Google Scholar][Crossref]
  28. Tiwari B, Fatima G, Hadi N, Fedacko J, Magomedova A, Raza AM, Alharis N, Qassam H, Alhmadi HB, Parvez S. Metal toxicity: significant health assessment. Kufa Medical Journal. 2024 Dec 1;20(2). doi:10.36330/kmj.v20i2.17957. [Google Scholar][Crossref]
  29. Pagliai G, Giangrandi I, Dinu M, Sofi F, Colombini B. Nutritional interventions in the management of fibromyalgia syndrome. Nutrients. 2020 Aug 20;12(9):2525. [Google Scholar][Crossref]
  30. Ahmad IZ, Parvez S, Tabassum H. Cyanobacterial peptides with respect to anticancer activity: structural and functional perspective. Studies in Natural Products Chemistry. 2020 Jan 1;67:345-88. doi:10.1016/B978-0-12-819483-6.00010-2. [Google Scholar][Crossref]
  31. Parvez S, Dzupina A, Fatima G, Fedacko J, Magomedova A, Mehdi AA. Unveiling the role of human PER3 gene polymorphism (rs57875989) as a potential risk factor in fibromyalgia syndrome International Journal of Medical and All Body Health Research www.allmedicaljournal.com patients. Cureus. 2024 Dec 6;16(12):e75210. doi:10.7759/cureus.75210. [Google Scholar][Crossref]
  32. González-Flores D, López-Pingarrón L, Castaño MY, Gómez MÁ, Rodríguez AB, García JJ, Garrido M. Melatonin as a coadjuvant in the treatment of patients with fibromyalgia. Biomedicines. 2023 Jul 12;11(7):1964. [Google Scholar][Crossref]
  33. Fatima G, Parvez S, Tuomainen P, Fedacko J, Kazmi DH, Elkilany GE. Amalgamation of circadian clock gene with incidence of myocardial infarction. Indian Journal of Cardiovascular Disease in Women. 2024:1-7. doi:10.25259/IJCDW_69_2023. [Google Scholar][Crossref]
  34. Parvez S, Fatima G. Unveiling the link between long COVID-19 and fibromyalgia. International Journal of Medical Research and General Education. 2025;6(1):1189-1192. doi:10.54660/.IJMRGE.2025.6.1.1189-1192. [Google Scholar][Crossref]
  35. Khoja O, Mulvey M, Astill S, Tan AL, Sivan M. New-onset chronic musculoskeletal pain following COVID-19 infection fulfils the fibromyalgia clinical syndrome criteria: a preliminary study. Biomedicines. 2024 Aug 23;12(9):1940. [Google Scholar][Crossref]
  36. Parvez S, Fatima G. Mini review: association between serum cortisol levels and COVID-19 disease. Era's Journal of Medical Research. 2021 Jul 1;8(2). doi:10.24041/ejmr2021.35. [Google Scholar][Crossref]
  37. Fatima G, Parvez S, Raza AM, Fedacko J, Hadi NR. COVID-19 and mucormycosis: a short report from India. Era's Journal of Medical Research. 2021;8(2). doi:10.24041/ejmr2021.38. [Google Scholar][Crossref]
  38. Parvez S, Fatima G, Hadi NR, Jha H. Early steam inhalation: the first crucial step in combating evil—the COVID-19. Era's Journal of Medical Research. 2021;8(1):82-4. doi:10.24041/ejmr2021.15. [Google Scholar][Crossref]
  39. Singh RB, Fatima G, Parvez S, Halabi G, Hadi N. Safety and efficacy of nebulization for reducing the intensity of viral load and clinical manifestations in patients with COVID-19. In: Features, Transmission, Detection, and Case Studies in COVID-19. Academic Press; 2024 Jan 1. p. 507-514. doi:10.1016/B978-0-323-95646-8.00054-8. [Google Scholar][Crossref]
  40. Parvez S, Fatima G, Al-Awaida W, Hussien YA, Tamam SA, Hadi NR. Vitamin D: implications in COVID-19. Latin American Journal of Pharmacy. 2021 Apr 1;40:23-6. [Google Scholar][Crossref]
  41. Fatima G, Siddiqui Z, Parvez S. AI and precision medicine: paving the way for future treatment. Preprints. 2024;2024120036. doi:10.20944/preprints202412.0036.v1. [Google Scholar][Crossref]
  42. Bajwa J, Munir U, Nori A, Williams B. Artificial intelligence in healthcare: transforming the practice of medicine. Future Healthcare Journal. 2021;8(2):188-194. [Google Scholar][Crossref]

How to Cite

Parvez, S., Fatima, G., Alhmadi, H. B., Hadi, N., & Fedacko, J. (2025). Fibromyalgia Syndrome: It’s more than just a mere syndrome. International Journal of Medical and All Body Health Research, 6(1), 74-79. https://doi.org/10.54660/IJMBHR.2025.6.1.74-79

Parvez, Sidrah, et al. "Fibromyalgia Syndrome: It’s more than just a mere syndrome." International Journal of Medical and All Body Health Research, vol. 6, no. 1, 2025, pp. 74-79. https://doi.org/10.54660/IJMBHR.2025.6.1.74-79.

Parvez, S., Fatima, G., Alhmadi, H. B., Hadi, N. and Fedacko, J. (2025) 'Fibromyalgia Syndrome: It’s more than just a mere syndrome', International Journal of Medical and All Body Health Research, 6(1), pp. 74-79. doi: 10.54660/IJMBHR.2025.6.1.74-79.

Parvez S, Fatima G, Alhmadi HB, Hadi N, Fedacko J. Fibromyalgia Syndrome: It’s more than just a mere syndrome. International Journal of Medical and All Body Health Research. 2025;6(1):74-79. doi:10.54660/IJMBHR.2025.6.1.74-79

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.